Cargando…

Lipid and renal profile in assessing the severity of alcoholic liver disease

Lipid and Renal dysfunction in Alcoholic liver disease (ALD) patients occurs either due to multi-organ involvement or secondary to alcoholism. This study was conducted to evaluate the role of lipid and renal parameters in assessing the severity of progression of ALD. Sixty cases of ALD (two groups b...

Descripción completa

Detalles Bibliográficos
Autores principales: G, Chitrasivasankari, V, Gomathi, R, Nachiappan, Kaarthikeyan, Gurumoorthy, S, Mahalakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465763/
https://www.ncbi.nlm.nih.gov/pubmed/37654846
http://dx.doi.org/10.6026/973206300181036
_version_ 1785098742502785024
author G, Chitrasivasankari
V, Gomathi
R, Nachiappan
Kaarthikeyan, Gurumoorthy
S, Mahalakshmi
author_facet G, Chitrasivasankari
V, Gomathi
R, Nachiappan
Kaarthikeyan, Gurumoorthy
S, Mahalakshmi
author_sort G, Chitrasivasankari
collection PubMed
description Lipid and Renal dysfunction in Alcoholic liver disease (ALD) patients occurs either due to multi-organ involvement or secondary to alcoholism. This study was conducted to evaluate the role of lipid and renal parameters in assessing the severity of progression of ALD. Sixty cases of ALD (two groups based on compensated and decompensated features) and thirty healthy controls for comparison were included. Lipid profile (Total Cholesterol, LDL, HDL and Triglycerides) and renal parameters (serum urea, creatinine and uric acid), total and direct bilirubin, total protein and albumin were measured using automated chemistry analyzer. There was a significant decrease in Total cholesterol ,LDL and HDL levels and increased triglycerides when compared to controls (mean of 128.4 ± 59 vs 155 ± 27.2, 77 ± 44.3 vs 97.4 ± 27.2, 28.3 ± 18 vs 39.5 ± 14.1 and 115.8 ± 70.4 vs 91 ± 38 mg/dL respectively). Lipid profile showed a linear decrease while progressing from compensated to decompensated ALD. Renal parameters revealed a statistically significant decrease in serum urea ,increased creatinine and uric acid levels when compared to controls (17.57±2.96 vs23.73±4.94, 1.12±0.55 vs0.88±0.16,6.60±1.32 vs 4.68±1.40 mg/dL respectively).Total cholesterol and HDL showed a linear decrease when ALD progresses. Serum uric acid showed an early increase in compensated stage of ALD. This study inferred that Total cholesterol, TGL, HDL and uric acid can be used for assessing the severity of progression of ALD.
format Online
Article
Text
id pubmed-10465763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-104657632023-08-31 Lipid and renal profile in assessing the severity of alcoholic liver disease G, Chitrasivasankari V, Gomathi R, Nachiappan Kaarthikeyan, Gurumoorthy S, Mahalakshmi Bioinformation Research Article Lipid and Renal dysfunction in Alcoholic liver disease (ALD) patients occurs either due to multi-organ involvement or secondary to alcoholism. This study was conducted to evaluate the role of lipid and renal parameters in assessing the severity of progression of ALD. Sixty cases of ALD (two groups based on compensated and decompensated features) and thirty healthy controls for comparison were included. Lipid profile (Total Cholesterol, LDL, HDL and Triglycerides) and renal parameters (serum urea, creatinine and uric acid), total and direct bilirubin, total protein and albumin were measured using automated chemistry analyzer. There was a significant decrease in Total cholesterol ,LDL and HDL levels and increased triglycerides when compared to controls (mean of 128.4 ± 59 vs 155 ± 27.2, 77 ± 44.3 vs 97.4 ± 27.2, 28.3 ± 18 vs 39.5 ± 14.1 and 115.8 ± 70.4 vs 91 ± 38 mg/dL respectively). Lipid profile showed a linear decrease while progressing from compensated to decompensated ALD. Renal parameters revealed a statistically significant decrease in serum urea ,increased creatinine and uric acid levels when compared to controls (17.57±2.96 vs23.73±4.94, 1.12±0.55 vs0.88±0.16,6.60±1.32 vs 4.68±1.40 mg/dL respectively).Total cholesterol and HDL showed a linear decrease when ALD progresses. Serum uric acid showed an early increase in compensated stage of ALD. This study inferred that Total cholesterol, TGL, HDL and uric acid can be used for assessing the severity of progression of ALD. Biomedical Informatics 2022-10-31 /pmc/articles/PMC10465763/ /pubmed/37654846 http://dx.doi.org/10.6026/973206300181036 Text en © 2022 Biomedical Informatics https://creativecommons.org/licenses/by/3.0/This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Research Article
G, Chitrasivasankari
V, Gomathi
R, Nachiappan
Kaarthikeyan, Gurumoorthy
S, Mahalakshmi
Lipid and renal profile in assessing the severity of alcoholic liver disease
title Lipid and renal profile in assessing the severity of alcoholic liver disease
title_full Lipid and renal profile in assessing the severity of alcoholic liver disease
title_fullStr Lipid and renal profile in assessing the severity of alcoholic liver disease
title_full_unstemmed Lipid and renal profile in assessing the severity of alcoholic liver disease
title_short Lipid and renal profile in assessing the severity of alcoholic liver disease
title_sort lipid and renal profile in assessing the severity of alcoholic liver disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465763/
https://www.ncbi.nlm.nih.gov/pubmed/37654846
http://dx.doi.org/10.6026/973206300181036
work_keys_str_mv AT gchitrasivasankari lipidandrenalprofileinassessingtheseverityofalcoholicliverdisease
AT vgomathi lipidandrenalprofileinassessingtheseverityofalcoholicliverdisease
AT rnachiappan lipidandrenalprofileinassessingtheseverityofalcoholicliverdisease
AT kaarthikeyangurumoorthy lipidandrenalprofileinassessingtheseverityofalcoholicliverdisease
AT smahalakshmi lipidandrenalprofileinassessingtheseverityofalcoholicliverdisease